Bernard Ravina, Chief Medical Officer at Voyager Therapeutics, Inc. (VYGR), sold 7,260 shares at $16.40 ($119K) on 2018-01-10, disclosed to the SEC on 2018-01-12.
Open-market sale of $119k VYGR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.40 | 3,630 | $60K | 50.0% |
| 2 | $16.40 | 3,630 | $60K | 50.0% |
| Total | $16.40 avg | 7,260 | $119K | 100% |
| Filing → |
| VYGR | SELL | 2018-02-13 | $45K | — | Filing → |
| VYGR | SELL | 2017-12-13 | $150K | — | Filing → |
| VYGR | SELL | 2017-11-13 | $146K | — | Filing → |